Equity Valuation Using Multiples: Comparables and Forecasted Fundamentals

Relative Value Equity Valuation Approaches

Relative valuation anchors a company’s worth against the market’s pricing of comparable assets. While the core concept—that similar assets should trade at similar prices—is intuitively simple, effective execution requires a disciplined, multi-layered approach.

The methodology is broken down into two distinct analytical frameworks: the Method of Comparables, which follows a systematic process to benchmark observed multiples against peer groups, and the Method of Forecasted Fundamentals, which derives mathematically grounded “justified” multiples from a firm’s underlying financial drivers.

We begin by outlining the rigorous five-step process of the comparables method, emphasizing the critical role of peer group selection, the alignment of market-value numerators with appropriate fundamental denominators, and the consistent calculation required for meaningful cross-company analysis.

We then pivot to the forecasted fundamentals approach, introducing key mathematical formulations—starting with the constant-growth dividend discount model to derive the justified:

\begin{align*} \frac{P}{B} &= \frac{ROE – g}{r_e – g} \end{align*}

relationship, and extending to the:

\begin{align*} PEG &= \frac{P/E}{g_{EPS}} \end{align*}

ratio for normalizing growth differences across peers.

To handle more complex scenarios, we explore regression techniques that simultaneously control for multiple value drivers (such as ROE, growth, and cost of equity), allowing analysts to estimate justified multiples while accounting for fundamental variations across the peer set.

Beyond the core methodologies, we demonstrate how these relative valuation tools integrate with discounted cash flow models—particularly in estimating terminal values using formulations like:

\begin{align*} E(P_{t+n}) &= (P/E)_{peer} \times EPS_{t+n} \end{align*}

Finally, we address the practical challenges that practitioners inevitably face, including timing discrepancies across reporting periods, the treatment of outliers in peer group distributions, and the biases introduced by non-recurring items.

The Method of Comparables: A Structured Approach

The method of comparables follows a systematic process to estimate relative value:

1. Step 1: Assemble a Peer Group – The first task is identifying companies that share similar risk profiles, growth trajectories, and cash flow characteristics with the target firm. While industry classification systems (such as GICS, ICB, or TRBC) provide useful starting points, analysts often need to look beyond simple industry codes. Two companies in different sectors might be comparable if they share similar fundamental drivers—for instance, a software company and a pharmaceutical firm might both exhibit high R&D intensity and recurring revenue models.
2. Step 2: Select Appropriate Multiples – Choosing the right multiple is critical. The numerator should represent market value (either equity value or enterprise value), while the denominator should capture a fundamental measure that reflects the company’s performance or position. The key is ensuring consistency—if the numerator reflects equity value, the denominator should represent an equity claim.
3. Step 3: Calculate and Compare Multiples – Once consistent definitions are established, analysts compute multiples across the peer group and position the target company within this distribution. Measures of central tendency (mean or median) typically serve as benchmarks for “fair value.” However, the distribution’s shape matters too—in positively skewed distributions, the median often provides a better reference point than the mean.
4. Step 4: Interpret the Findings – A company trading significantly above peer multiples might be overvalued, while one trading well below might represent an undervalued opportunity. However, analysts must exercise caution: differences in multiples often reflect legitimate variations in underlying fundamentals, not mispricing.
5. Step 5: Use Multiples in Conjunction with DCF – Multiples can serve dual purposes: they provide standalone relative value estimates and can be integrated into discounted cash flow models, particularly for estimating terminal values.

The Challenge of Peer Group Construction

Selecting an appropriate peer group is arguably the most consequential step in relative valuation. Ideally, comparable companies should exhibit similar cash flow characteristics (stability, cyclicality, growth patterns), risk profiles (business, financial, and operational risk), and growth prospects (both near-term and long-term). While industry classification provides a useful starting point, truly effective peer group construction often requires more nuanced analysis. A company might operate in a specific industry but have fundamentally different business characteristics from its apparent peers—a pharmaceutical company focused on generics versus one pioneering novel treatments would have vastly different risk-return profiles.

The Method of Forecasted Fundamentals

Beyond simply comparing observed multiples, sophisticated analysts use the method of forecasted fundamentals to understand what a company’s multiple should be based on its underlying characteristics. This approach bridges relative valuation with fundamental analysis.

The Justified Multiple Concept

A justified multiple represents what a company’s multiple would be if it were fairly valued, given its fundamental characteristics. The foundation for deriving these justified multiples is the constant-growth dividend discount model:

\begin{align*} P_t &= \frac{Div_{t+1}}{r_e – g} \end{align*}

Where:

\( P_t \) is the intrinsic value per share at time \( t \),

\( Div_{t+1} \) is the next period’s expected dividend,

\( r_e \) is the required rate of return on equity, and \( g \) is the constant perpetual growth rate.

To derive a justified Price-to-Book (P/B) multiple, we divide both sides of the DDM by the book value of equity per share (\( BVE_t \)):

\begin{align*} \frac{P_t}{BVE_t} &= \frac{Div_{t+1}/BVE_t}{r_e – g} \end{align*}

Recognizing that \( Div_{t+1} = EPS_{t+1} \times \text{Payout Ratio} \) and that \( ROE = \frac{EPS}{BVE} \), we substitute to obtain:

\begin{align*} \frac{P_t}{BVE_t} &= \frac{ROE \times \text{Payout Ratio}}{r_e – g} \end{align*}

Furthermore, the sustainable growth rate links these fundamentals as $$ g = (1 – \text{Payout Ratio}) \times ROE $$. Rearranging this gives $$ ROE \times \text{Payout Ratio} = ROE – g $$. Substituting this back yields the most elegant and widely used version of the justified P/B:

\begin{align*} \frac{P_t}{BVE_t} &= \frac{ROE – g}{r_e – g} \end{align*}

This compact formula reveals that the P/B multiple is fundamentally a function of the spread between a company’s ROE and its cost of equity. Firms generating ROE significantly above their required return should command higher multiples, while those with subpar profitability will trade at discounts. The relative size of this spread determines valuation—a more rapidly growing company should inherently have a higher multiple.

Adjusting for Growth Differences: The PEG Ratio

The PEG (Price/Earnings-to-Growth) ratio adjusts P/E multiples to account for varying growth expectations across comparable firms. It is defined mathematically as:

\begin{align*} PEG &= \frac{\text{P/E Multiple}}{\text{Expected EPS Growth Rate (%)}} \end{align*}

More formally, using trailing figures:

\begin{align*} PEG &= \frac{P_t / EPS_t}{g_{EPS}} \end{align*}

or, using forward figures,

\begin{align*} PEG &= \frac{P_t / EPS_{t+1}}{g_{EPS}} \end{align*}

Where \( g_{EPS} \) represents the expected percentage growth in earnings per share (typically expressed as a whole number, such as 15 for 15%).

Consider three beverage companies with identical P/E ratios but vastly different growth prospects—a mature soda manufacturer, a fast-growing energy drink company, and a premium water brand. The PEG ratio helps normalize these differences. A company with a higher P/E but proportionally higher growth expectations might actually appear more attractive on a PEG-adjusted basis. In contrast, a high P/E with stagnant growth would reveal an overvalued stock. The higher the PEG ratio, the more likely a stock is to be overvalued, assuming the growth rate is comparable across peers.

Regression-Based Approaches for Estimating Justified Multiples

When multiple fundamental factors simultaneously drive a multiple, regression analysis provides a more sophisticated comparative framework than single-variable adjustments. For instance, because the P/B multiple is influenced by ROE, growth rates, and the cost of equity simultaneously, an analyst might gather data across a peer set and estimate the following cross-sectional regression:

\begin{align*} \left(\frac{P}{B}\right)_i &= \alpha + \beta_1 \cdot ROE_i + \beta_2 \cdot g_i + \beta_3 \cdot r_{e,i} + \varepsilon_i \end{align*}

Here, the subscript \( i \) indexes each firm in the peer group, \( \alpha \) is the regression intercept, \( \beta_1 \), \( \beta_2 \), and \( \beta_3 \) are the estimated coefficients, and \( \varepsilon_i \) is the error term (the residual).

The predicted (or “justified”) multiple for any firm is calculated as:

\begin{align*} \text{Predicted } (P/B)_i &= \alpha + \beta_1 \cdot ROE_i + \beta_2 \cdot g_i + \beta_3 \cdot r_{e,i} \end{align*}

The residual \( \varepsilon_i \) represents the unexplained difference between the firm’s actual multiple and the regression-predicted justified multiple:

\begin{align*} \varepsilon_i &= \text{Actual } (P/B)_i – \text{Predicted } (P/B)_i \end{align*}

A firm is considered potentially undervalued if its actual multiple is significantly lower than its predicted multiple (i.e., \( \varepsilon_i \) is large and negative). Conversely, a large positive residual suggests overvaluation. This approach combines the method of comparables (by incorporating data from all peers) with the method of forecasted fundamentals (by using fundamental drivers as explanatory variables) without rigidly relying on the constant-growth model’s strict assumptions.

Terminal Value Estimation Using Multiples in DCF Frameworks

Multiples frequently appear in discounted cash flow valuations, particularly when estimating terminal value. The standard present value formula captures the value of explicit forecasted cash flows plus a terminal value:

\begin{align*} IV_0 &= \sum_{t=1}^{n} \frac{E(CF_t)}{(1+r_t)^t} + \frac{E(P_{t+n})}{(1+r_n)^n} \end{align*}

Rather than assuming a perpetual growth rate, analysts often estimate the terminal value \( E(P_{t+n}) \) by applying a peer group multiple to a projected fundamental variable. For example, using a trailing P/E multiple on forecasted earnings in the terminal year:

\begin{align*} E(P_{t+n}) &= (P/E)_{peer} \times EPS_{t+n} \end{align*}

Substituting this back into the DCF formula yields the integrated valuation expression:

\begin{align*} IV_0 &= \sum_{t=1}^{n} \frac{E(FCFE_t)}{(1+r_e)^t} + \frac{(P/E)_{peer} \times EPS_{t+n}}{(1+r_e)^n} \end{align*}

Where \( E(FCFE_t) \) represents the expected free cash flow to equity in each forecast period, \( n \) is the explicit forecast horizon, and \( EPS_{t+n} \) is the projected earnings per share at the end of the forecast period. This hybrid approach leverages the market’s consensus view (via the peer multiple) while anchoring the valuation in the company’s specific cash flow projections. However, caution is warranted—today’s peer group multiples may not be appropriate for measuring terminal value years into the future, especially if industry dynamics or growth expectations are likely to change significantly.

Practical Applications and Timing Considerations

Timing and Consistency Issues

When comparing multiples across companies, analysts must address several challenges:

• Valuation date misalignment requires that stock prices be measured at the same point in time.
• Accounting differences can distort earnings, book values, and other denominator measures.
• Non-recurring items (such as one-time gains or losses) can significantly affect earnings-based multiples.
• Additionally, reporting period discrepancies arise because companies may have different fiscal year-ends. For instance, comparing three retailers with different quarterly reporting periods would distort price-to-book ratios not only due to differing price measurement dates but also because of corporate actions (like share buybacks or dividend payments) that occurred between their respective reporting dates and the comparison date.

Managing Outliers

Extreme values in peer group multiples require careful handling. A company with negative earnings (making its P/E ratio meaningless) or an unusually high multiple due to extraordinary circumstances might need to be excluded. However, removing outliers arbitrarily can introduce bias—analysts should develop consistent, well-justified criteria for inclusion or exclusion.

Final Thoughts on Relative Valuation

Relative valuation offers intuitive appeal and practical simplicity, but its apparent ease can be deceptive. Successful application requires disciplined peer group construction, thoughtful multiple selection, and consistent calculation, a deep understanding of underlying fundamental drivers (as captured mathematically by justified multiples like \( \frac{ROE – g}{r_e – g} \), recognition that multiple differences may reflect legitimate factors rather than mispricing, and integration with other valuation approaches like DCF.

When applied rigorously—with formulas serving as precise guides rather than rigid rules—relative valuation provides a valuable complement to absolute valuation methods. It offers market-based perspectives that can confirm or challenge DCF-derived estimates. The most effective analysts combine multiple approaches, using each to cross-validate conclusions and build a comprehensive, mathematically grounded understanding of a company’s true worth.

Example 1: Justified P/B and PEG Ratio Analysis

An equity analyst is evaluating three companies in the specialty chemicals sector: AlphaChem, BetaWorks, and GammaCorp.

The analyst has gathered the following actual trading data and fundamental forecasts for each firm:

\begin{array}{l|l|l|l|l|l}
\textbf{Firm} & \textbf{Actual P/B} & \textbf{Trailing P/E} & \textbf{ROE} & \textbf{Required Return } (r_e) & \textbf{Expected EPS Growth } (g) \\
\hline
\text{AlphaChem} & 2.50 & 18.0\text{x} & 14.0\% & 9.0\% & 5.0\% \\
\hline
\text{BetaWorks} & 1.80 & 22.0\text{x} & 11.0\% & 8.0\% & 4.0\% \\
\hline
\text{GammaCorp} & 4.20 & 30.0\text{x} & 20.0\% & 10.0\% & 7.0\% \\
\end{array}

1. Using the constant-growth justified P/B formula, calculate each firm’s theoretical fair multiple and determine whether each stock is overvalued, fairly valued, or undervalued relative to its fundamentals.
2. Calculate the PEG ratio for each firm and interpret whether the P/E rankings change after adjusting for growth expectations.

Solution to Question 1:

The justified P/B formula derived from the Gordon Growth model is:

$$ \text{Justified P/B} = \frac{ROE – g}{r_e – g} $$

AlphaChem:
$$ \text{Justified P/B} = \frac{0.14 – 0.05}{0.09 – 0.05} = \frac{0.09}{0.04} = 2.25 $$

Since  Actual (2.50) > Justified (2.25). The stock is trading above what its fundamentals justify; it is overvalued.

BetaWorks:

$$ \text{Justified P/B} = \frac{0.11 – 0.04}{0.08 – 0.04} = \frac{0.07}{0.04} = 1.75 $$

Since the actual (1.80) is moderately above the justified (1.75), the premium is small, suggesting it is slightly overvalued or trading within a reasonable tolerance band.

GammaCorp:
$$ \text{Justified P/B} = \frac{0.20 – 0.07}{0.10 – 0.07} = \frac{0.13}{0.03} = 4.33 $$

Notice that Actual (4.20) < Justified (4.33). The market is not fully pricing in GammaCorp’s superior ROE spread relative to its cost of equity and hence undervalued.

Solution to Question 2:

The PEG ratio normalizes the P/E multiple by the expected earnings growth rate:

$$ \begin{align*} PEG &= \frac{\text{Trailing P/E}}{g} \end{align*} $$

Note: \( g \) is expressed as a whole number in the denominator (e.g., 5 for 5%).

AlphaChem:

$$ PEG = \frac{18.0}{5} = 3.60 $$

BetaWorks:

$$ PEG = \frac{22.0}{4} = 5.50 $$

GammaCorp:

$$ PEG = \frac{30.0}{7} = 4.29 $$

Interpretation:

$$ \begin{array}{l|l|l}
\text{Firm} & \text{P/E Rank (1=highest)} & \text{PEG Rank (1=lowest)} \\
\hline
\text{AlphaChem} & \text{3rd (lowest P/E)} & \text{1st (lowest PEG)} \\
\hline
\text{BetaWorks} & \text{2nd} & \text{3rd (highest PEG)} \\
\hline
\text{GammaCorp} & \text{1st (highest P/E)} & \text{2nd} \\
\end{array} $$

While GammaCorp has the highest raw P/E (30.0x), its robust 7% growth expectation brings its PEG ratio down to 4.29, making it appear more reasonable on a growth-adjusted basis. Conversely, BetaWorks has a lower P/E than GammaCorp, but its sluggish 4% growth results in the highest PEG (5.50), signaling that it is the most overvalued relative to its growth prospects. AlphaChem, despite having the lowest P/E, actually offers the best growth-adjusted value (lowest PEG).

Example 2: Regression-Based Justified Multiple and Terminal Value Integration

An equity analyst is conducting a valuation for TransGlobal Logistics Inc., a mid-cap logistics company. The analyst has identified five comparable firms and runs a cross-sectional regression of their P/B multiples against two fundamental drivers: ROE and expected growth rate \( g \). The regression output yields the following estimated coefficients:

$$ \begin{align*} \text{Predicted P/B} &= -1.50 + 25.0 \times ROE + 30.0 \times g \end{align*}
$$

Other current data is as follows:

• Actual P/B = 3.00
• ROE = 16% (0.16)
• Expected growth (\( g \)) = 5% (0.05)

In a separate exercise, the analyst forecasts the firm’s Free Cash Flow to Equity (FCFE) for the next 3 years and plans to use a peer-derived multiple for the terminal value. The forecasted data is:

• Forecasted FCFE: Year 1 = $100M, Year 2 = $115M, Year 3 = $130M
• Cost of equity (\( r_e \)) = 10%
• Forecasted EPS at the end of Year 3 = $8.00
• Peer group median trailing P/E = 15.0x

1. Calculate the regression-predicted justified P/B for TransGlobal, determine the residual, and interpret whether the firm is mispriced.
2. Using the P/E multiple to estimate terminal value, calculate the total intrinsic value of TransGlobal’s equity today.

Solution to Question 1:

Step 1: Calculate the predicted justified P/B
Plug TransGlobal’s fundamentals into the regression equation:
$$ \begin{align*} \text{Predicted P/B} & = -1.50 + (25.0 \times 0.16) + (30.0 \times 0.05) \\
\text{Predicted P/B} & = -1.50 + 4.00 + 1.50 = 4.00 \end{align*} $$

Step 2: Calculate the regression residual
The residual (\( \varepsilon \)) is the unexplained difference between the actual multiple and the predicted justified multiple:
$$ \begin{align*} \varepsilon & = \text{Actual P/B} – \text{Predicted P/B} = 3.00 – 4.00 = -1.00 \end{align*} $$

Interpretation:

The regression model, which controls for both ROE and growth, suggests that TransGlobal’s fundamentals warrant a P/B of 4.00x. However, the actual market multiple is only 3.00x, resulting in a negative residual (-1.00). This indicates that the stock is trading significantly below the level predicted by its fundamentals.

Conclusion: TransGlobal appears undervalued relative to its peers, controlling for profitability and growth.

Solution to Question 2:

Step 1: Estimate the terminal value at the end of Year 3
Using the peer group P/E multiple applied to the forecasted EPS at the terminal year:
\( \text{Terminal Value} = (P/E)_{peer} \times EPS_{t+n} \)
\( \text{Terminal Value} = 15.0 \times \$8.00 = \$120.00 \text{ million} \)

Step 2: Calculate the present value of the explicit FCFE forecast
Discount each year’s FCFE at the 10% cost of equity:
\( PV(FCFE_1) = \frac{\$100}{1.10^1} = \frac{100}{1.10} = \$90.91 \text{ million} \)
\( PV(FCFE_2) = \frac{\$115}{1.10^2} = \frac{115}{1.21} = \$95.04 \text{ million} \)
\( PV(FCFE_3) = \frac{\$130}{1.10^3} = \frac{130}{1.331} = \$97.67 \text{ million} \)
Sum of PV of explicit FCFE:
$$ \sum_{t=1}^{3} PV(FCFE_t) = 90.91 + 95.04 + 97.67 = \$283.62 \text{ million} $$

Step 3: Calculate the present value of the terminal value
Since the terminal value is estimated as a Year 3 future amount, discount it back three periods:
$$ PV(\text{Terminal Value}) = \frac{\$120.00}{1.10^3} = \frac{120}{1.331} = \$90.16 \text{ million} $$

Step 4: Sum all components to find the total intrinsic equity value
$$ IV_0 = \sum_{t=1}^{n} \frac{E(FCFE_t)}{(1+r_e)^t} + \frac{(P/E)_{peer} \times EPS_{t+n}}{(1+r_e)^n} $$
Substitute the calculated amounts:
$$ IV_0 = \$283.62 \text{ million} + \$90.16 \text{ million} = \$373.78 \text{ million} $$

Final Interpretation: Based on the integrated relative valuation approach (using peer multiples for the terminal value) combined with explicit DCF projections, TransGlobal’s estimated intrinsic equity value is approximately $373.8 million. If the firm’s current market capitalization is significantly below this figure, it would reinforce the undervaluation signal suggested by the regression residual in Task A. This demonstrates how the method of comparables (via the terminal multiple) and the method of forecasted fundamentals (via explicit cash flow projections) work together in a hybrid valuation model.